Organoids are defined as three-dimensional (3D) cell culture systems that can be called “mini-organs” as they mimic some of the key multicellular, anatomical and even functional characteristics of real organs. Organoids are praised as a substitute for animal models in preclinical studies. At the same time, organoid technology raises issues around informed consent or privacy of donors.
This panel discussion features multidisciplinary experts discussing ethical, regulatory, and scientific aspects of organoid technology. Following a brief introduction in organoid research, a special focus will be placed on biobanking from the patient perspective. The panellists will discuss trust, trustworthiness, therapeutic misconception, and the need for regulation. They will also challenge definitions and the consequences of terminology such as ‘donation’ and ‘mini-organ’.
Join us on 31 October at 15:00 CEST. Register online.
Moderator: Melanie Goisauf
Speakers: Zisis Kozlakidis, María Berdasco Menéndez, Signe Mežinska, and Mike Lensink
Access to Detailed Speaker Profiles
This webinar is a collaborative effort between the ELSI Services & Research Department and the Stakeholder Forum Patient Pillar of BBMRI-ERIC.